The high costs of CPAP machines are a burden for patients with sleep apnea; these costs are only partially covered by Medicare in the United States, while other countries do not cover any CPAP costs. Medical visits to multiple locations, as well as the inconvenient and high cost of diagnosis and therapy, create a significant barrier for patients. The massive pool of undiagnosed sleep apnea patients holds enormous potential for the Sleep Apnea Devices Growth. The untouched patient base is expected to be diagnosed and treated for sleep apnea as a result of ongoing awareness campaigns and efforts. People are increasingly choosing home sleep apnea tests (HSATs) due to the affordability and convenience of sleep apnea management at home. Telemedicine has grown in popularity.
Read More- https://coherentmarketinsightsus.blogspot.com/2022/09/sleep-apnea-devices-help-in-breathing.html
